Literature DB >> 18313348

Proteinase-activated receptors (PARs) in infection and inflammation in the gut.

Nathalie Vergnolle1.   

Abstract

Proteinases have been shown to act as signaling molecules that are able to send specific signals to cells through the activation of proteinase-activated receptors (PARs). Those receptors which are expressed in a wide variety of cells in the gastrointestinal tract are considered as "emergency" mechanisms, particularly involved in inflammatory responses of the gut. Depending on the cell types of the gut in which PARs are activated, their activation interacts with all aspects of the gut physiology: motility, barrier function, transports, innate immune response, sensory functions, and even proliferation. A growing body of evidences discussed here suggests that these receptors, and the proteinases that activate them, are important mediators of the innate immune response of the gut and could play a major role in chronic inflammatory states of the gut (inflammatory bowel diseases), or infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18313348     DOI: 10.1016/j.biocel.2008.01.016

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  8 in total

1.  Serine protease inhibition reduces post-ischemic granulocyte recruitment in mouse intestine.

Authors:  Thomas Gobbetti; Nicolas Cenac; Jean-Paul Motta; Corinne Rolland; Laurence Martin; Patricia Andrade-Gordon; Martin Steinhoff; Elisabetta Barocelli; Nathalie Vergnolle
Journal:  Am J Pathol       Date:  2011-11-07       Impact factor: 4.307

2.  Contribution of bone marrow-derived cells to the pro-inflammatory effects of protease-activated receptor-2 in colitis.

Authors:  Eric Hyun; Patricia Andrade-Gordon; Martin Steinhoff; Paul L Beck; Nathalie Vergnolle
Journal:  Inflamm Res       Date:  2010-03-26       Impact factor: 4.575

Review 3.  Protease inhibition as new therapeutic strategy for GI diseases.

Authors:  Nathalie Vergnolle
Journal:  Gut       Date:  2016-04-12       Impact factor: 23.059

4.  Protease-activated receptor 2 signaling modulates susceptibility of colonic epithelium to injury through stabilization of YAP in vivo.

Authors:  Longmei He; Yiming Ma; Weiwei Li; Wenxiao Han; Xinhua Zhao; Hongying Wang
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

5.  Latent-period stool proteomic assay of multiple sclerosis model indicates protective capacity of host-expressed protease inhibitors.

Authors:  Carlos G Gonzalez; Stephanie K Tankou; Laura M Cox; Ellen P Casavant; Howard L Weiner; Joshua E Elias
Journal:  Sci Rep       Date:  2019-08-28       Impact factor: 4.379

Review 6.  Protease-Activated Receptors in the Intestine: Focus on Inflammation and Cancer.

Authors:  Morgane Sébert; Nuria Sola-Tapias; Emmanuel Mas; Frédérick Barreau; Audrey Ferrand
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-24       Impact factor: 5.555

7.  Intestinal protease-activated receptor-2 and fecal serine protease activity are increased in canine inflammatory bowel disease and may contribute to intestinal cytokine expression.

Authors:  Shingo Maeda; Koichi Ohno; Kazuyuki Uchida; Hirotaka Igarashi; Yuko Goto-Koshino; Yasuhito Fujino; Hajime Tsujimoto
Journal:  J Vet Med Sci       Date:  2014-05-15       Impact factor: 1.267

8.  Proteinase Activated Receptor 4 in the Jejunum of Healthy Horses and of Horses With Epiploic Hernia.

Authors:  Carlotta Lambertini; Cristiano Bombardi; Augusta Zannoni; Chiara Bernardini; Francesco Dondi; Maria Morini; Riccardo Rinnovati; Alessandro Spadari; Noemi Romagnoli
Journal:  Front Vet Sci       Date:  2020-03-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.